Alar Pharmaceuticals Inc. (TPEX:6785)

Alar Pharmaceuticals Revenue

Alar Pharmaceuticals had revenue of 1.25M TWD in the quarter ending June 30, 2026, a decrease of -0.24%. This brings the company's total for the last twelve months to 3.00M, down -57.57% year-over-year. In the year 2025, Alar Pharmaceuticals had annual revenue of 2.75M, down -52.67%. That makes Alar Pharmaceuticals the 46,112th largest company in the world by revenue and 2,194th in Taiwan.

• Revenue (ttm): 3.00M
• Revenue Growth: -57.57%
• P/S Ratio: 1,919.39
• Revenue / Employee: n/a
• Employees: 32
• Market Cap: 6.03B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Taiwan 1.50M 54.5%
• United Kingdom 1.25M 45.5%

Fiscal year ended Dec 31, 2025 See the full Alar Pharmaceuticals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.75M	-3.06M	-52.67%
Dec 31, 2024	5.82M	-463.46M	-98.76%
Dec 31, 2023	469.27M	468.47M	58,559.00%
Dec 31, 2022	800.00K	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 16, 2026

Data Sources Report a data error